MedPath

Optical Coherence Tomography Guided C&D

Not Applicable
Withdrawn
Conditions
Basal Cell Carcinoma
Interventions
Device: Optical Coherence Tomography (OCT)
Procedure: Curettage & Desiccation (C&D) Procedure
Registration Number
NCT04510727
Lead Sponsor
University of Miami
Brief Summary

The purpose of the study is to identify the presence of residual superficial and nodular basal cell carcinoma (BCC) status-post curettage and desiccation (C\&D) by using optical coherence tomography (OCT).

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Patients of any: age, gender, Fitzpatrick skin type and ethnicity.
  • Primary BCC of any type, except aggressive types that fit the criteria for Mohs surgery
  • No prior treatment on the lesion within the last 3 months.
  • Lesions anywhere except the head, neck and distal extremities.
  • Willing and able to sign informed consent
Exclusion Criteria
  • Aggressive BCC types.
  • Recurrent tumors.
  • Lesion treated within last 3 months.
  • Lesions on head and neck (high risk areas)
  • Lesions on distal extremities (thin epidermis not preferred for OCT).
  • Pregnant women.
  • Patients less than 18 years old.
  • Prisoners.
  • Any other condition or circumstance that, in the opinion of the Investigator, may compromise the subject's ability to comply with the study protocol

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
OCT Guided C&D GroupOptical Coherence Tomography (OCT)Participants in this group will receive OCT imaging immediately prior, immediately after and 2 months after post standard of care C\&D.
OCT Guided C&D GroupCurettage & Desiccation (C&D) ProcedureParticipants in this group will receive OCT imaging immediately prior, immediately after and 2 months after post standard of care C\&D.
Primary Outcome Measures
NameTimeMethod
The incidence of residual basal cell carcinoma tumor cells2 months (post C&D procedure)

The incidence of residual superficial and nodular basal cell carcinoma tumor cells after standard of care C\&D as assessed using the OCT.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Maria V Muniz

🇺🇸

Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath